ABREVA RAPID PAIN RELIEF- glycerin, lidocaine gel 
Haleon US Holdings LLC

----------

Drug Facts

Active ingredients

Glycerin 20%

Lidocaine HCl 4%

Purposes

Lip Protectant

External Analgesic

Uses

for the temporary relief of pain and itching associated with cold sores and fever blisters
Relieves dryness and softens cold sores and fever blisters
Softens crust (scabs) associated with cold sores and fever blisters

Warnings

For external use only

Do not use

 
in large quantities, particularly over raw surfaces, or blistered areas

When using this product

 
do not get into eyes

Stop use and ask a doctor if

condition worsens
symptoms last more than 7 days or clear up and occur again within a few days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

push and turn cap to open, close tightly after use
wash hands before and after applying
adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daily
children under 12 years: consult a doctor

Other information

store at 20-25oC (68o-77oF)

Inactive ingredients

edetate disodium, hydroxyethyl cellulose, menthol, methylparaben, polysorbate 80, propylene glycol,

propylparaben, trisodium citrate dihydrate, water

Questions or comments?

1-877-709-3539

Additional Information

Retain outer carton for full product uses, directions and warnings.

Do not use if carton is broken or damaged.

CARTON Recycle

Trademarks are owned by or licensed to the Haleon group of companies.

Distributed by:

Haleon

Warren, NJ 07059

Made in Canada

©2023 Haleon group of companies or its licensor.

Principal Display Panel

abreva

RAPID

PAIN RELIEF

Cold Sore

MAX

STRENGTH

LIDOCAINE

For rapid numbing effect

Lidocaine HCl 4% / Glycerin 20%

External Analgesic / Lip Protectant

NET WT 3 g (0.10 oz)

PA 202119 – Front Panel

PA 202119 Abreva Rapid Pain Relief 3g
ABREVA  RAPID PAIN RELIEF
glycerin, lidocaine gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0135-0400
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN200 mg  in 1 g
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS40 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0135-0400-011 in 1 PACKAGE06/01/2023
13 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01706/01/2023
Labeler - Haleon US Holdings LLC (079944263)

Revised: 2/2024
Document Id: 0095d2b2-17b9-4a35-99e2-14a1dfccd87b
Set id: 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d
Version: 2
Effective Time: 20240208
 
Haleon US Holdings LLC